Connection

Amarendra Neppalli to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications Amarendra Neppalli has written about Antineoplastic Agents, Immunological.
Amarendra Neppalli
Connection Strength
0.038
Antineoplastic Agents, Immunological
  1. Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy. Leukemia. 2019 09; 33(9):2266-2275.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.